Correlation between Helicobacter pylori infection and atherosclerosis in a physical examination population and its

Lei Han1, Ruijuan Gu2, Hatira Jingsihan1

  • 1Center of Health Management, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830054, China.

Insights

Helicobacter pylori (HP) infection, especially high-risk strains, is linked to increased carotid atherosclerosis (AS) in individuals undergoing physical exams. High-risk HP infection is a significant risk factor for carotid plaque formation.

Area of Science:

  • Cardiovascular Medicine
  • Infectious Diseases
  • Public Health

Background:

  • Carotid atherosclerosis (AS) is a major risk factor for stroke.
  • Helicobacter pylori (HP) infection is prevalent and linked to various systemic conditions.
  • The association between HP infection and AS requires further investigation in general populations.

Purpose of the Study:

  • To determine the impact of Helicobacter pylori (HP) infection on carotid atherosclerosis (AS).
  • To assess HP infection as a risk factor for carotid plaque (CP) formation in a physical examination cohort.

Main Methods:

  • A cohort of physical examination patients was enrolled.
  • Participants underwent 13C-urea breath test (13C-UBT) for HP detection and carotid ultrasound for AS assessment.
  • Multivariate logistic regression analyzed risk factors for CP formation.

Main Results:

  • HP-infected individuals had higher BMI, LDL-C, and uric acid levels compared to non-infected individuals.
  • High-risk HP infection was associated with significant differences in age, BMI, hypertension, cholesterol, and uric acid.
  • Age, smoking, systolic blood pressure, and glycosylated hemoglobin were CP risk factors between infected and non-infected groups.

Conclusions:

  • Helicobacter pylori infection, particularly high-risk HP, accelerates carotid AS in the physical examination population.
  • High-risk HP infection is identified as a risk factor for carotid plaque development.
Abstract

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
524
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
79
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
118
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
319
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
342
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
218